ML P19 8 mg (Doxazosin Mesylate 8 mg)
Pill with imprint ML P19 8 mg is Green, Elliptical / Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Dava Pharmaceuticals Inc..
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ML P19 8 mg
Doxazosin Mesylate
- Imprint:
- ML P19 8 mg
- Strength:
- 8 mg
- Color:
- Green
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Dava Pharmaceuticals Inc.
- National Drug Code (NDC):
- 67253-0383
- Inactive Ingredients:
-
- microcrystalline cellulose
- sodium starch glycolate type B potato
- magnesium stearate
- sodium lauryl sulfate
- FD&C Blue No. 2
- D&C Yellow No. 10
- aluminum oxide
- lactose
Note: Inactive ingredients may vary.
More about doxazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 39 Reviews
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
Other brands: Cardura, Cardura XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
